The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-morpholinopropan-2-yl)-6-(8-(thiophen-2-yl)-1H-imidazo[4,5-c][1,7]naphthyridin-1-yl)benzo[d]thiazol-2-amine ID: ALA3918552
PubChem CID: 134140223
Max Phase: Preclinical
Molecular Formula: C27H25N7OS2
Molecular Weight: 527.68
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(CN1CCOCC1)Nc1nc2ccc(-n3cnc4cnc5cnc(-c6cccs6)cc5c43)cc2s1
Standard InChI: InChI=1S/C27H25N7OS2/c1-17(15-33-6-8-35-9-7-33)31-27-32-20-5-4-18(11-25(20)37-27)34-16-30-23-14-29-22-13-28-21(12-19(22)26(23)34)24-3-2-10-36-24/h2-5,10-14,16-17H,6-9,15H2,1H3,(H,31,32)
Standard InChI Key: BIPRHBIWZRMDCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 43 0 0 0 0 0 0 0 0999 V2000
3.6388 -7.8799 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.3861 -8.2102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9298 -7.6037 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5212 -6.8946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7229 -7.0654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1750 -6.4589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4297 -5.6817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2281 -5.5109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7759 -6.1174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0526 -2.6383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3435 -3.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3435 -3.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0526 -4.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7617 -3.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4667 -4.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1757 -3.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1757 -3.0469 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4666 -2.6383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7617 -3.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0714 -5.1592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7370 -4.4119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8818 -5.0752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8848 -4.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5580 -9.0091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3358 -9.2597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5076 -10.0586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2855 -10.3093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4507 -11.1066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2245 -11.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8335 -10.8126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6634 -10.0123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8842 -9.7574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9417 -8.7114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9672 -5.0830 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.7679 -5.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1765 -4.5433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6283 -3.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
5 6 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
10 19 1 0
14 19 1 0
20 21 2 0
20 22 1 0
12 21 1 0
13 22 1 0
16 23 1 0
7 22 1 0
2 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
27 32 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
25 33 1 0
23 34 1 0
34 35 1 0
35 36 2 0
36 37 1 0
37 23 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 527.68Molecular Weight (Monoisotopic): 527.1562AlogP: 5.44#Rotatable Bonds: 6Polar Surface Area: 80.99Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.64CX LogP: 4.41CX LogD: 4.34Aromatic Rings: 6Heavy Atoms: 37QED Weighted: 0.31Np Likeness Score: -1.98
References 1. Glatthar R, Stojanovic A, Troxler T, Mattes H, Möbitz H, Beerli R, Blanz J, Gassmann E, Drückes P, Fendrich G, Gutmann S, Martiny-Baron G, Spence F, Hornfeld J, Peel JE, Sparrer H.. (2016) Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors., 59 (16): [PMID:27502541 ] [10.1021/acs.jmedchem.6b00598 ]